首页> 外文期刊>American journal of therapeutics >Therapeutic Modulation of Aortic Stiffness
【24h】

Therapeutic Modulation of Aortic Stiffness

机译:主动脉僵硬的治疗性调制

获取原文
获取原文并翻译 | 示例
           

摘要

Aortic stiffness (AS) is an important predictor of cardiovascular morbidity in humans. The present review discusses the possible pathophysiological mechanisms of AS and focuses on a survey of different therapeutic modalities for decreasing AS. The influence of several nonpharmacological interventions is described: decrease body weight, diet, aerobic exercise training, music, and continuous positive airway pressure therapy. The effects of different pharmacological drug classes on AS are also discussed: antihypertensive drugsrenin-angiotensin-aldosterone system drugs, beta-blockers, alpha-blockers, diuretics, and calcium channel blockers (CCBs)advanced glycation end product cross-link breakers, statins, oral anti-diabetics, anti-inflammatory drugs, vitamin D, antioxidant vitamins, and endothelin-1 receptor antagonists. All of these have shown some effect in decreasing AS.
机译:主动脉僵硬度(AS)是人类心血管疾病发病率的重要预测指标。本综述讨论了AS的可能的病理生理机制,并着重于减少AS的不同治疗方式的调查。描述了几种非药物干预的影响:减轻体重,饮食,有氧运动训练,音乐和持续正压通气疗法。还讨论了不同药理类型的药物对AS的影响:降压药肾素-血管紧张素-醛固酮系统药物,β-受体阻滞剂,α-受体阻滞剂,利尿剂和钙通道阻滞剂(CCB),先进的糖化终产物交联剂,他汀类药物,口服抗糖尿病药,抗炎药,维生素D,抗氧化剂维生素和内皮素-1受体拮抗剂。所有这些都显示出降低AS的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号